Testing effectiveness (Phase 2)UnknownNCT04426578What this trial is testingRole of Perhexiline in Hypertrophic CardiomyopathyWho this might be right forHypertrophic Cardiomyopathy Flinders University 60
Not applicableStudy completedNCT02549664What this trial is testingExercise in Genetic Cardiovascular ConditionsWho this might be right forHypertrophic CardiomyopathyLong QT Syndrome Yale University 4,299
Very early researchStudy completedNCT07033455What this trial is testingA Trial of HRS-1893 in Healthy VolunteersWho this might be right forHypertrophic Cardiomyopathy Atridia Pty Ltd. 20
Post-approval studies (Phase 4)Ended earlyNCT01272388What this trial is testingAortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot StudyWho this might be right forAortic Stenosis Washington University School of Medicine 1
Post-approval studies (Phase 4)WithdrawnNCT01275352What this trial is testingCLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy RegressionWho this might be right forHypertension Washington University School of Medicine
Not applicableStudy completedNCT02395107What this trial is testingLeft Atrial Volume Index in Asymptomatic Aortic StenosisWho this might be right forAortic Valve StenosisHeart Failure Odense University Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT01230918What this trial is testingStudy to Develop a Non-invasive Marker for Monitoring Myocardial FibrosisWho this might be right forHypertrophic CardiomyopathyAcute Coronary Syndrome Ottawa Heart Institute Research Corporation 120
Early research (Phase 1)Study completedNCT02329184What this trial is testingStudy Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461Who this might be right forHypertrophic Cardiomyopathy MyoKardia, Inc. 15
Testing effectiveness (Phase 2)WithdrawnNCT01556568What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic CardiomyopathyWho this might be right forCardiomegaly Array Biopharma, now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT01873976What this trial is testingCardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers)Who this might be right forDilated CardiomyopathyHypertrophic Cardiomyopathy Wayne State University 288
Not applicableLooking for participantsNCT05332691What this trial is testingTransapical Beating-heart Septal Myectomy in Patient With Hypertrophic Obstructive CardiomyopathyWho this might be right forHypertrophic Obstructive Cardiomyopathy Xiang Wei 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06481891What this trial is testingEvaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyWho this might be right forObstructive Cardiomyopathy, HypertrophicNon-obstructive Hypertrophic Cardiomyopathy Lexicon Pharmaceuticals 500
Post-approval studies (Phase 4)Study completedNCT03180593What this trial is testingEfficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVHWho this might be right forHypertension ComplicatedHypertrophy, Left VentricularBlood Pressure Trinity Hypertension & Metabolic Research Institute 30
Not applicableUnknownNCT06169358What this trial is testingScreening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular HypertrophyWho this might be right forHypertrophic CardiomyopathyLeft Ventricular HypertrophyFabry Disease Qilu Hospital of Shandong University 627
Not applicableLooking for participantsNCT03549559What this trial is testingImaging Histone Deacetylase in the HeartWho this might be right forHeart Failure With Normal Ejection FractionLeft Ventricular HypertrophyAortic Valve Stenosis+1 more Massachusetts General Hospital 96
Not applicableEnded earlyNCT01427374What this trial is testingRisk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis PatientsWho this might be right forEnd Stage Renal Disease University of Alberta 30
Not applicableUnknownNCT01442350What this trial is testingMyocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of BiomarkersWho this might be right forFabry Disease, Cardiac VariantRight Ventricular Hypertrophy Francisco Marín Ortuño 120
Post-approval studies (Phase 4)Study completedNCT01951404What this trial is testingDoes ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED StudyWho this might be right forEnd Stage Renal DiseaseLeft Ventricular Hypertrophy University of Dundee 80
Not applicableUnknownNCT03040947What this trial is testingMRI Sequence and Imaging Protocol DevelopmentWho this might be right forCardiomyopathy, HypertrophicCardiomyopathy, DilatedLeft Ventricular Hypertrophy+2 more National Heart Centre Singapore 200
Not applicableUnknownNCT02520856What this trial is testingNew Diagnostic Strategy in Hypertrophic CardiomyopathyWho this might be right forHypertrophic Cardiomyopathy Assistance Publique Hopitaux De Marseille 200